REGenableMED Advisory Group

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Carol Bewick, Director of Policy and Communications, for Fight for Sight

Angela Blake, Head of Outcomes Research, Evidence Based Medicine and HTA Policy, Pfizer UK

Edmund Jessop, Highly Specialised Services, NHS England

Panos Kefalas, Head of the Health Economics and Market Access Cell and Gene Therapy Catapult

Tony Pagliuca, National Clinical Director for RM, NHSE Kings College Hospital, London

Magda Papadaki, Head of Manufacturing Innovation and Manager of the Medicines Manufacturing Industry Partnership (MMIP) for the ABPI

Fiona Marley, Head of Highly Specialised Commissioning, NHS England

Kath Mackay, Head of Precision and Discovery Medicine, Innovate UK

Robert McNabb Professor Emeritus, Department of Economics, Cardiff University

Bernie Stocks, Commissioning Manager Highly Specialised Services, NHS England

Mike Sullivan, Head of Advanced Therapies, Innovate UK

Ahmed Syed, Specialised Services NHS England